TrialLeukemia2012

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

U Platzbecker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.